217 related articles for article (PubMed ID: 14708234)
41. Is repeat transurethral resection effective and necessary in patients with T1 bladder carcinoma?
Yucel M; Hatipoglu NK; Atakanli C; Yalcinkaya S; Dedekarginoglu G; Saracoglu U; Aras E
Urol Int; 2010; 85(3):276-80. PubMed ID: 20733272
[TBL] [Abstract][Full Text] [Related]
42. The role of lymphadenectomy in high-grade invasive bladder cancer.
Stein JP; Skinner DG
Urol Clin North Am; 2005 May; 32(2):187-97. PubMed ID: 15862616
[TBL] [Abstract][Full Text] [Related]
43. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
[TBL] [Abstract][Full Text] [Related]
44. Restaging transurethral resection for non-muscle invasive bladder cancer: who, why, when, and how?
Ritch CR; Clark PE; Morgan TM
Urol Clin North Am; 2013 May; 40(2):295-304. PubMed ID: 23540786
[TBL] [Abstract][Full Text] [Related]
45. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
[TBL] [Abstract][Full Text] [Related]
46. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
Moschini M; Karnes RJ; Sharma V; Gandaglia G; Fossati N; Dell'Oglio P; Cucchiara V; Capogrosso P; Shariat SF; Damiano R; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
Eur J Surg Oncol; 2016 May; 42(5):735-43. PubMed ID: 26927300
[TBL] [Abstract][Full Text] [Related]
47. Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years.
Haber GP; Gill IS
BJU Int; 2007 Jul; 100(1):137-42. PubMed ID: 17552961
[TBL] [Abstract][Full Text] [Related]
48. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
Urologiia; 2004; (6):37-40. PubMed ID: 15719729
[TBL] [Abstract][Full Text] [Related]
49. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer.
Stein JP; Skinner DG
BJU Int; 2003 Jul; 92(1):12-7. PubMed ID: 12823375
[No Abstract] [Full Text] [Related]
50. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
[TBL] [Abstract][Full Text] [Related]
51. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
[TBL] [Abstract][Full Text] [Related]
52. [Is partial cystectomy a justified intervention in the treatment of bladder tumors?].
Filimon C; Novac C; Gheorghiu V; Costache C; Pricop C; Todosi L; Negru I; Suditu N; Caba D; Roznovanu S; Rusu E; Mihaela R
Rev Med Chir Soc Med Nat Iasi; 1997; 101(1-2):170-3. PubMed ID: 10756749
[TBL] [Abstract][Full Text] [Related]
53. Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study.
Bruins HM; Skinner EC; Dorin RP; Ahmadi H; Djaladat H; Miranda G; Cai J; Daneshmand S
Urol Oncol; 2014 Jan; 32(1):24.e13-9. PubMed ID: 23395238
[TBL] [Abstract][Full Text] [Related]
54. Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer.
Zehnder P; Thalmann GN
Curr Opin Urol; 2013 Sep; 23(5):423-8. PubMed ID: 23880740
[TBL] [Abstract][Full Text] [Related]
55. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
57. Performing radical cystectomy and urinary diversion in regional anesthesia: potential risk reduction in the treatment of bladder cancer.
Friedrich-Freksa M; Schulz E; Nitzke T; Wenzel O; Popken G
Urol Int; 2013; 91(1):103-8. PubMed ID: 23752480
[TBL] [Abstract][Full Text] [Related]
58. [Analysis of Clinical, Histopathological and Follow-Up Data on Transurethral Resections of the Bladder Performed during One Year at a University Centre].
Otto W; Fritsche HM; Dirmeyer M; Burger M; Straub M; Rössler W; Wieland WF; Denzinger S
Aktuelle Urol; 2010 Sep; 41(5):316-9. PubMed ID: 20669097
[TBL] [Abstract][Full Text] [Related]
59. [Staging of urinary bladder tumors with CT and MRI].
Akmangit I; Lakadamyali H; Oto A; Ozen H; Akhan O; Besim A
Tani Girisim Radyol; 2003 Mar; 9(1):63-9. PubMed ID: 14661295
[TBL] [Abstract][Full Text] [Related]
60. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
Parekh DJ; Bochner BH; Dalbagni G
J Clin Oncol; 2006 Dec; 24(35):5519-27. PubMed ID: 17158537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]